Condition: Chronic Kidney Diseases · Diabetic Kidney Disease · Sponsor: Renalytix AI, Inc.
The purpose of this study is to assess the impact of the KidneyIntelX assay utilized as part of the current standard of care on the management of patients seen in the primary care physician's office at Mount Sinai.
This description comes directly from the study's public registry record.
Roger Tun · 646-397-3970 · rtun@renalytix.com
Always discuss trial participation with your own doctor first.
| Mount Sinai Health System | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04802395